08.01.2019 • NewsAdamaElaine Burridge

Adama in Talks to Take China’s Anpon

Adama in Talks to Take China’s Anpon (c) Adama
Adama in Talks to Take China’s Anpon (c) Adama

Israeli crop protection producer Adama, a subsidiary of ChemChina, has disclosed that it is making “significant progress” towards acquiring China’s Jiangsu Anpon Electrochemical.

Also a wholly owned subsidiary of ChemChina, Anpon is a fully backward-integrated manufacturer of key active ingredients used in crop protection markets worldwide, notably ethephon, pymetrozine and buprofezin, as well as other intermediates such as chloralkali. It posted sales of around $234 million in 2017.

Adama said Anpon is fast becoming a key part of its global operations, adding synthesis and formulation capabilities to its operations in China. Anpon’s site in Huai’An City, Jiangsu province, is located next to Adama’s new global formulation facility. The Israeli producer added that work at its R&D center in Nanjing, China, is also resulting in major process improvements in Anpon’s production processes.

Both companies have reached an initial understanding and are now working towards signing a definitive purchase agreement, which will remain subject to corporate and regulatory approvals along with the usual closing conditions.  They have not given a timescale for the proposed transaction or any financial details.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.